- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Patent holdings for IPC class A61K 47/26
Total number of patents in this class: 10189
10-year publication summary
|
746
|
763
|
883
|
924
|
1084
|
1028
|
1015
|
1065
|
1027
|
38
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4458 |
97 |
| Amgen Inc. | 4275 |
79 |
| Azurity Pharmaceuticals, Inc. | 231 |
71 |
| Takeda Pharmaceutical Company Limited | 2707 |
70 |
| Novartis AG | 10506 |
61 |
| Genentech, Inc. | 4014 |
61 |
| Allergan, Inc. | 2307 |
56 |
| Pfizer Inc. | 3391 |
48 |
| Chiesi Farmaceutici S.p.A. | 960 |
46 |
| Hoffmann-La Roche Inc. | 3567 |
43 |
| Merck Sharp & Dohme LLC | 3737 |
43 |
| Chugai Seiyaku Kabushiki Kaisha | 1391 |
41 |
| Janssen Biotech, Inc. | 1597 |
41 |
| Alkermes Pharma Ireland Limited | 259 |
40 |
| Daiichi Sankyo Company, Limited | 1877 |
40 |
| Astellas Pharma Inc. | 1048 |
38 |
| Hanmi Pharm. Co., Ltd. | 586 |
37 |
| F. Hoffmann-La Roche AG | 7896 |
36 |
| Arecor Limited | 105 |
30 |
| Coherus Biosciences, Inc. | 120 |
30 |
| Other owners | 9181 |